» Articles » PMID: 23052031

Cardioprotection by Ischemic Postconditioning is Abrogated in Hypertrophied Myocardium of Spontaneously Hypertensive Rats

Overview
Date 2012 Oct 12
PMID 23052031
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study examines if ischemic postconditioning is preserved in hypertrophied myocardium of spontaneously hypertensive rats (SHR).

Methods: Infarct sizes, hemodynamic, morphometric, and biochemical parameters were obtained from normotensive controls [Wistar-Kyoto (WKY) rats] and compared with SHRs. In open-chest rats, the infarct size was determined after 30 minutes of regional ischemia. Postconditioning was performed by 3 cycles of ischemia/reperfusion with 30 seconds each or 6 cycles of ischemia/reperfusion with 10 seconds each immediately after the infarction.

Results: Infarct size was comparable between control rats and SHRs. In WKY rats, postconditioning reduced the infarct size significantly. However, in SHRs, the postconditioning effect was completely lost for both postconditioning protocols. Even shortening of the ischemic period to 20 minutes did not restore the infarct sparing effect in SHRs. The phosphorylation of glycogen synthase kinase 3β increased 2.1-fold by ischemic postconditioning in WKY rats; however, this increase was completely absent in SHRs with both postconditioning protocols.

Conclusions: Myocardial hypertrophy inhibits the protection by postconditioning in an experimental animal model. Future studies have to clarify whether this result can be extrapolated to patients with arterial hypertension and myocardial hypertrophy.

Citing Articles

High-density lipoprotein protects normotensive and hypertensive rats against ischemia-reperfusion injury through differential regulation of mTORC1 and mTORC2 signaling.

Al-Othman R, Al-Jarallah A, Babiker F Front Pharmacol. 2024; 15:1398630.

PMID: 39611167 PMC: 11603114. DOI: 10.3389/fphar.2024.1398630.


Comparison of Cardioprotective Potential of Cannabidiol and β-Adrenergic Stimulation Against Hypoxia/Reoxygenation Injury in Rat Atria and Ventricular Papillary Muscles.

Pedzinska-Betiuk A, Gergs U, Weresa J, Remiszewski P, Harasim-Symbor E, Malinowska B Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459019 PMC: 11509923. DOI: 10.3390/ph17101379.


High-Density Lipoprotein Signaling via Sphingosine-1-Phosphate Receptors Safeguards Spontaneously Hypertensive Rats against Myocardial Ischemia/Reperfusion Injury.

Al-Jarallah A, Babiker F Pharmaceutics. 2024; 16(4).

PMID: 38675158 PMC: 11054943. DOI: 10.3390/pharmaceutics16040497.


Dexmedetomidine as a cardioprotective drug: a narrative review.

Takahashi K, Yoshikawa Y, Kanda M, Hirata N, Yamakage M J Anesth. 2023; 37(6):961-970.

PMID: 37750978 DOI: 10.1007/s00540-023-03261-w.


Age-Dependent Effects of Remote Preconditioning in Hypertensive Rat Hearts are Associated With Activation of RISK Signaling.

Farkasova F, Kindernay L, Ferko M, Rajtik T, Szobi A, Ravingerova T Physiol Res. 2023; 72(S1):S11-S22.

PMID: 37294114 PMC: 10292815. DOI: 10.33549/physiolres.935019.